Detection of a novel mammalian protein phosphatase with activity for phosphotyrosine  by Foulkes, J.Gordon et al.
Volume 130, number 2 FEBS LETTERS August 198 1 
DETECTION OF A NOVEL MAMMALIAN PROTEIN PHOSPHATASE WITH ACTIVITY FOR 
PHOSPHOTYROSINE 
J. Gordon FOULKES+p*, Randall F. HOWARD** and Andrew ZIEMIECKI** 
+Department of Biochemistry, Medical Sciences Institute, University of Dundee, Scotland and Department of Physiology, M. S. 
Hershey Medical Center, University of Pennsylvania, Hershey, PA 17033, USA and **Institut fiir Virologie, Fachbereich 
Humanmedizin der Justus-Liebig-Universittit Giessen, Frankfurter Str. 10 7, D-6300 Giessen, FRG 
Received 2 June 1981 
1. Introduction 
A novel protein kinase activity specifically phos- 
phorylating tyrosine residues has recently been 
demonstrated [ 1,2], and several cellular proteins 
have been shown to contain phosphate on tyrosine 
[3]. At least two cellular regulatory systems, the EGF 
receptor and the (Na’ + K+)-ATPase, have now been 
reported to be phosphorylated at tyrosine residues 
[4-61. Furthermore, cells transformed by Rous 
sarcoma virus contain up to lo-fold elevated levels 
of phosphotyrosine [7]. This has led to speculation 
that phosphorylation of tyrosine may be important 
in transformation by this virus [7]. 
In many cases where a metabolic pathway has 
been shown to be effected by phosphorylation, its 
regulation appears to be the sum of a kinase/phos- 
phatase interaction [8,9]. With this in mind we have 
looked in cell extracts for activity capable of removing 
phosphate from tyrosine residues. Using IgG heavy- 
chain phosphorylated exclusively at tyrosine as a 
substrate, we have demonstrated a phosphatase activ- 
ity capable of dephosphorylating phosphotyrosine. 
This phosphotyrosine phosphatase activity has prop- 
erties which are significantly different from those of 
previously described mammalian phosphatases [9]. 
2. Materials and methods 
1gG heavy chain 32P-labelled in tyrosine was used 
as a substrate in our assays for phosphotyrosine phos- 
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phatase activity. Labelled IgG heavy chain was pre- 
pared as described by Collett and Erikson [ 11, making 
use of the phosphotyrosine kinase activity present in 
immunoprecipitates of Rous sarcoma virus-trans- 
formed cell extracts and tumor-bearing rabbit serum. 
Labelled heavy chain was resolved on 11% sodium 
dodecylsulfate (SDS)-polyacrylamide gels [lo], 
located by exposing X-ray film (Kodak) to wet gels, 
excised, and simultaneously eluted and dialysed 
against 0.05 M NH4HC03, pH 8.0 containing 0.1% 
SDS at 37°C for 20 h. Prior to lyophilization, the 
heavy chain was dialysed for 4 h at 37°C against 
0.05 M NH4HC03, pH 8.0. Acid hydrolysis and thin- 
layer electrophoresis of the phosphoamino acids [2] 
showed that the heavy chain prepared by the above 
procedure had better than 95% of the phosphate on 
tyrosine (fig.l), and that in the lyophilized form it 
was stable at room temperature for at least 3 weeks. 
Rat muscle and liver extracts were used as a source 
of phosphotyrosine phosphatase (PTP) activity. Tis- 
sue was homogenized for 30 sin a Polytron (Brinkman) 
with 3 volumes of ice-cold buffer (10 mM Tris-HCl, 
pH 7.8 at 25”C, containing 4 mM EDTA, 30 mM 
2-mercaptoethanol, 250 mM sucrose). Extracts were 
clarified by centrifugation at 6000 X g for 40 min at 
4°C and desalted by gel filtration on Sephadex G-50 
into 50 mM Tris-HCl, pH 7.0 at 25°C containing 
30 mM 2-mercaptoethanol. The PTP assay, modified 
from a phosphorylase phosphatase assay [ 111, con- 
sisted of preincubating at 30°C 20 fi of diluted tissue 
extract with 20 d of 50 mM Tris-HCl, pH 7.0 at 
25°C containing the additions indicated. Five min 
later the reaction was initiated by the addition of 
20 d 32P-labelled IgG heavy chain (4000 cpm) in 
50 mM Tris-HCl, pH 7.0 at 25°C. The reaction was 
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terminated after 20 min at 30°C by the addition of 
100 ~120% trichloroacetic acid. Protein-bound 32P 
was quantitatively precipitated by adding 100 /*l of a 
10 mg/ml solution of bovine serum albumin, incubat- 
ing at room temperature for 10 min, and microcen- 
trifugation for 2 min. An aliquot of the trichloroacetic 
acid supernatant (150 ~1) was counted in Liquiscint 
(National Diagnostics, Somerville, NJ). As an alterna- 
tive to measuring trichloroacetic acid-soluble 32P, the 
32P released was determined to be inorganic phos- 
phate by the molybdate extraction procedure 
described by Antoniw and Cohen [ 121. Briefly, 100 /*l 
of the supernatant from the trichloroacetic acid- 
treated reaction mixture was mixed with 200 ~1 of 
1.25 mM KH2P04 in 0.5 M H2S04, 500 ~1 of iso- 
butanol:toluene (1: 1 j and 100 ~1 5% ammonium 
molybdate. After vigorous shaking, the upper organic 
phase containing the inorganic 32P was removed and 
counted in a scintillation counter. 
32P-labelled phosphorylase a was prepared and 
phosphorylase phosphatase activity was assayed as 
described by Foulkes and Cohen [I I]. All other 
materials were reagent grade or better. 
3. Results 
We have used the heavy chain of IgG specifically 
radiolabelled with 32P at tyrosine (fig.1) as a sub- 
strate for phosphotyrosine phosphatase (PTP) activ- 
ity. Tissue extracts prepared from rat muscle and liver 
yielded a phosphatase activity capable of dephos- 
phorylating the heavy chain. A typical result is shown 
in fig.2. Both the liver and muscle extracts catalysed 
the release of 32P in a time-dependent manner, and 
the specific activity of this reaction was similar for 
the two tissues. Zinc was capable of significantly 
inhibiting the reaction rate when either the muscle 
(fig.2) or the liver (data not shown) extracts were 
used. The release of 32P was biphasic with respect to 
time. This was not due to enzyme inactivation since, 
if fresh enzyme was added to the reaction mixture 
at 20 min, there was no second burst of activity 
during a subsequent 5-min incubation. Furthermore, 
additional experiments demonstrated that both the 
initial and later rates of dephosphorylation were Zn*’ 
sensitive and F- insensitive (data not shown). 
Table 1 shows the effect of various agents on the 
phosphotyrosine phosphatase activity demonstrable 
in rat muscle extracts. The effect of these reagents 
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Fig.1. SDS-polyacrylamide gel electrophoretic resolution of 
32P-labelled IgG heavy chain (a) and its phosphoaminoacid 
analysis (b). (a) 32P-labelled heavy chain prepared as described 
in Materials and methods was re-electrophoresed on 11% 
SDS-polyacrylamide gels in order to confnm that after lyo- 
philization the ‘*P remained covalently bound to the heavy 
chain (53 K). (b) The positions of the marker phosphoamino- 
acids phosphothreonine, phosphoserine and phosphotyrosine 
are indicated. 
Fig.2. Time course of the phosphotyrosine phosphatase reac- 
tion. Tissue extracts and 32P-labelled 1gG heavy chain were 
prepared and the FTP activity assayed as described in Materials 
and methods. The liver and muscle extracts were diluted to 
2.4 mg protein ml-’ and 1.3 mg protein ml-‘, respectively, 
in 50 mM Tris-HCI, pH 7.0, at 25’C, containing 30 mM 
2-mercaptoethanol. The reaction mixture contained approx. 
4000 cpm per reaction tube. 
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Table 1 
Effect of various agents on phosphotyrosine phosphatase 
activity as a percentage of control values 
Additions Phosphotyrosine Phosphorylase 
phosphatase phosphatase 
activity activity 
None 100 100 
+ 1 mM EDTA 92 93 
+ 50 units phosphatase 
inhibitor-2 + EDTA 94 33a 
+ 1 mM MnCl, 78 90 
+ 1 mM Mg acetate 85 104 
+ 100 PM CaCl, 97 103 
+ 100 PM Zn acetate 15 107 
+ 150 mM KCl 30 38 
+50mMF-+lmM 
EDTA 95b o-o.2 
+ 95”C, 4-min treated 
extract 0 0 
a The phosphorylase phosphatase activity of rat muscle 
extracts is due to two different protein phosphatases 
termed protein phosphatase-1 and protein phosphatase-2b 
(J. G. Foulkes, unpublished observation). Protein phos- 
phatase-1, the major activity, is inhibited by inhibitor-2 
whereas protein phosphatase-2b is not [ 91 
b Activity is calculated relative to 50 mM KCl; the high ionic 
strength alone was slightly inhibitory 
Rat muscle extracts were incubated with either 32P-labelled 
IgG heavy chain (phosphotyrosine phosphatase activity) or 
32P-labelled phosphorylase a (phosphorylase phosphatase 
activity) as described in the Materials and methods. Enzyme 
activity (20 min reaction at 30°C) in the presence of the 
various reagents is given as a percentage of the activity in the 
absence of additions, each the average of duplicates for two 
determinations 
on the phosphorylase phosphatase activity present 
in the same extracts is shown for comparison. It is 
significant that inhibitor-:!, a specific inhibitor of the 
broad specificity enzyme known as protein phos- 
phatase-1 [ 111, and sodium fluoride have little effect 
on the PTP activity while rendering the phosphorylase 
phosphatase activity of protein phosphatase-1 practi- 
cally inactive. On the other hand, Zn’+ greatly reduced 
the PTP activity while having no effect on protein 
phosphatase-1 activity. This was quite specific for 
Zn’+ since the other divalent cations tested (Mn’+, 
Mg2+, Ca2’) were largely without effect. Similar 
observations, i.e., the F-/EDTA and phosphatase 
inhibitor-2 insensitivity of the PTP activity, were also 
made with the rat liver extracts. 
Measurement of the trichloroacetic acid-soluble 
32P in the standard PTP assay does not preclude the 
possibility that the solubilized label was produced by 
a proteolytic activity in the crude tissue extract. 
Therefore, a molybdate-organic solvent extraction 
technique was used which quantitatively separates 
inorganic phosphate from 32P-radiolabelled peptides. 
This method demonstrated that 100% of the trichlo- 
roacetic acid-soluble counts removed from the 32P- 
labelled IgG heavy chain by the tissue extract was 
recovered as inorganic 32P (results not shown). This 
inorganic “P was not the result of H2S04 hydrolysis 
during the molybdate-organic solvent fractionation 
since no inorganic 32P was recovered when tissue 
extract was omitted from the reaction with 32P-labelled 
1gG heavy chain prior to the solvent fractionation. 
4. Discussion 
Using a protein probe radiolabelled specifically at 
tyrosine, we have been able to demonstrate a phos- 
photyrosine phosphatase activity in rat muscle and 
liver tissues. This activity is distinct from the broad 
specificity enzyme termed protein phosphatase-1 not 
only in its substrate specificity, but also in its sensi- 
tivity to Zn2+ and its insensitivity to F-/EDTA and 
phosphatase inhibitor-2 [9,1 l]. (As these studies were 
nearing completion, Dr D. Brautigan, Dept. Biochem- 
istry, Univ. of Washington at Seattle, USA, reported 
at the EMBO-Meeting on Protein Phosphorylation in 
Villejuif, March 1981, that he had identified a phos- 
photyrosine phosphatase with similar properties.) The 
biphasic nature of the PTP reaction with 32P-labelled 
IgG heavy chain may indicate that there are several 
sites for tyrosine phosphorylation on the IgG heavy 
chain, some of which are especially susceptible to 
dephosphorylation. It is also significant that the PTP 
activity was not restricted to a single cell type, but 
was observed in extracts of both rat liver and muscle, 
suggesting the ubiquity of this enzymatic activity. 
(The Zn2+- sensitive, sodium fluoride-insensitive activ- 
ity is also present in extracts of uninfected and ROUS 
sarcoma virus infected chicken embryo fibroblasts. 
R. F. Howard and A. Ziemiecki, unpublished observa- 
tions.) 
It follows that, since cells possess an endogenous 
phosphotyrosine protein phosphatase activity as well 
as tyrosine-specific protein kinases [3-71, cells can 
probably dynamically regulate their levels of phos- 
photyrosine. It is as yet unclear whether the elevated 
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levels of phosphotyrosine found in cells transformed 
by Rous sarcoma virus [7] are due solely to increased 
protein kinase activity or to reduced protein phos- 
phatase activity, or to both. Nevertheless, the demon- 
stration of both phosphorylating and dephosphorylat- 
ing activities suggests that transformation is associated 
with an imbalance in the kinase/phosphatase regula- 
tion of tyrosine phosphorylation of certain proteins. 
It will be meaningful to determine whether correction 
of this imbalance can restore the metabolic regulation 
typical of cells prior to transformation. 
Acknowledgements 
The authors wish to thank Drs Philip Cohen, 
Robert R. Friis and L. S. Jefferson for helpful discus- 
sions and for use of their laboratory facilities during 
the course of these studies. This work was supported 
by the Deutsche Forschungsgemeinschaft (Sonderfor- 
schungsbereich 47, Virologie) and the British Diabetic 
Association (to Philip Cohen). R. F. Howard was a 
recipient of a U.S. National Institutes of Health - 
General Medical Sciences Postdoctoral Fellowship 
(GM 06868). 
References 
111 
121 
131 
141 
151 
161 
171 
181 
191 
1101 
1111 
1121 
Collett, M. S. and Erikson, R. L. (1978) Proc. Natl. 
Acad. Sci. USA 75, 2021-2024. 
Hunter, T. and Sefton, B. M. (1980) Proc. Natl. Acad. 
Sci. USA 77,1311-1315. 
Cooper, J. A. and Hunter, T. (1981) Mol. Cell. Biol. 1, 
165-178. 
Ushiro, H. and Cohen, S. (1980) J. Biol. Chem. 255, 
8363-8365. 
Spector, M., O’Neil, S. and Racker, E. (1980) J. Biol. 
Chem. 255,8370-8373. 
Spector, M., O’Neil, S. and Racker, E. (1981) J. Biol. 
Chem. in press. 
Sefton, B. M., Hunter, T., Beemon, K. and Eckhart, W. 
(1980) Cell 20, 8077816. 
Krebs, E. G. and Beavo, J. A. (1979) Annu. Rev. Bio- 
them. 48,923 -959. 
Cohen, P., Foulkes, J. G., Goris, J. Hemmings, B., 
Ingebritsen, T. S. and Stewart, A. A. (1981) in: Metab- 
olic Interconversion of Enzymes (Holzer, H., Helmreich, 
E. and Wieland, 0.. eds), Springer-Verlag, Heidelberg, 
in press. 
Laemmli, U. K. (1970) Nature 227,680-685. 
Foulkes, J. G. and Cohen, P. (1980) Eur. J. Biochem. 
lOS, 195-203. 
Antoniw, J. F. and Cohen, P. (1976) Eur. J. Biochem. 
68.45-54. 
200 
